Although ARDS is a serious medical condition associated with a very high mortality rate, the application of evidence-based therapies (e.g., lower tidal volume mechanical ventilation) have been shown to be cost-effective.
Acute respiratory distress syndrome cost-effectiveness of therapy
Bacterial pneumonia cost-effectiveness of therapy
Pneumonia cost-effectiveness of therapy
Hospital-acquired pneumonia cost-effectiveness of therapy
Acute respiratory distress syndrome classification
Acute respiratory distress syndrome future or investigational therapies
Hemothorax cost-effectiveness of therapy
Aspiration pneumonia classification